Sign in

CIK 0001842952

  • Emerging growth company

Context Therapeutics Inc.

Sign in to watch
Ticker
CNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
863738787
Phone
+1 267-225-7416
Business address
2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
Former names
Context Therapeutics LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-24 Walker Luke Nathaniel Director Grant or award · Stock Option (right to buy) +45,000 45,000
2025-06-12 Walker Luke Nathaniel Director Grant or award · Stock Option (right to buy) +123,500 123,500
2024-09-04 Walker Luke Nathaniel Director Grant or award · Stock Option (right to buy) +19,315 19,315

Page 1 of 1 · 3 trades